Lewis Relton

Lewis Relton is a seasoned professional in the pharmaceuticals and clinical research sectors, currently serving as the Senior Manager of Early Access at Alnylam Pharmaceuticals since September 2022. Prior experience includes roles such as Senior Expanded Access and Business Analytics Manager at WEP Clinical from January 2019 to August 2022, and various positions in expanded access program management, enhancing clinical trial accessibility. Lewis has also worked as a Business Analyst at Lifescience Dynamics Limited and held multiple managerial roles in clinical trials at Re:Cognition Health Ltd from October 2013 to March 2018. Educational achievements include a Mini MBA from Birkbeck, University of London, and a Bachelor of Science (Hons) in Biomedical Science from the University of Warwick.